Ende, Jonathan .
HRN: 22-12-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/31/2022
11/07/2022
IV
800 Mg
Q8
T/C Kawasaki R/O Strep Infection
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes